Molecular chaperones as rational drug targets for Parkinson's disease therapeutics.
Kalia
S K
SK
Department of Neurology, Massachusetts General Hospital, Mass General Institute for Neurodegenerative Disease, 114 16th Street, Charlestown, MA 02129, USA.
Kalia
L V
LV
McLean
P J
PJ